Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UK-369,003 dose-ranging study in men with lower urinary tract symptoms with or without erectile dysfunction
2006-004378-28Phase 2Completed
- Sponsor
- Pfizer
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of gisadenafil besylate in Micturition disorder and erectile dysfunction (ED) (4 arms), sponsored by Pfizer. Primary endpoint: Change in International Prostate Symptom Score total score. Started Nov 2006; status: completed.
02
Drugs
gisadenafil besylate
03
Conditions
Micturition disordererectile dysfunction (ED)
Beyond the preview
Go deeper on 2006-004378-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004378-28.